Innovation Medical(SZ:002173) Sou Hu Cai Jing·2025-09-15 15:11Core Viewpoint - Innovation Medical (002173) reported a closing price of 24.38 yuan on September 15, 2025, with a 1.58% increase, indicating a positive market response despite mixed fund flows [1] Group 1: Stock Performance and Fund Flows - On September 15, 2025, the stock had a turnover rate of 16.27%, with a trading volume of 677,500 hands and a transaction amount of 1.652 billion yuan [1] - The net outflow of main funds was 17.4485 million yuan, accounting for 1.06% of the total transaction amount, while the net inflow of speculative funds was 24.0722 million yuan, representing 1.46% of the total [1][2] - Retail investors experienced a net outflow of 6.6237 million yuan, which is 0.4% of the total transaction amount [1][2] Group 2: Recent Financial Performance - For the first half of 2025, Innovation Medical reported a main revenue of 402 million yuan, a year-on-year decrease of 1.6%, while the net profit attributable to shareholders was -11.3613 million yuan, an increase of 29.12% year-on-year [3] - The second quarter of 2025 saw a single-quarter main revenue of 208 million yuan, a year-on-year increase of 0.73%, and a net profit attributable to shareholders of 2.5761 million yuan, up 119.74% year-on-year [3] - The company’s gross profit margin stood at 12.06%, significantly lower than the industry average of 35.92% [3] Group 3: Company Metrics and Industry Comparison - Innovation Medical's total market value is 10.759 billion yuan, compared to the industry average of 21.569 billion yuan, ranking 15th out of 42 in the medical services sector [3] - The company has a negative price-to-earnings ratio of -473.47, while the industry average is 85.14, indicating significant underperformance [3] - The debt ratio is reported at 18.03%, with investment income of -2.5952 million yuan and financial expenses of 3.603 million yuan [3]